These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 25118797)

  • 1. Metabotropic glutamate receptor 5 as a potential therapeutic target in Huntington's disease.
    Ribeiro FM; Hamilton A; Doria JG; Guimaraes IM; Cregan SP; Ferguson SS
    Expert Opin Ther Targets; 2014 Nov; 18(11):1293-304. PubMed ID: 25118797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mGluR5 positive allosteric modulator, CDPPB, ameliorates pathology and phenotypic signs of a mouse model of Huntington's disease.
    Doria JG; de Souza JM; Andrade JN; Rodrigues HA; Guimaraes IM; Carvalho TG; Guatimosim C; Dobransky T; Ribeiro FM
    Neurobiol Dis; 2015 Jan; 73():163-73. PubMed ID: 25160573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabotropic glutamate receptor 5 positive allosteric modulators are neuroprotective in a mouse model of Huntington's disease.
    Doria JG; Silva FR; de Souza JM; Vieira LB; Carvalho TG; Reis HJ; Pereira GS; Dobransky T; Ribeiro FM
    Br J Pharmacol; 2013 Jun; 169(4):909-21. PubMed ID: 23489026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Huntington's disease and Group I metabotropic glutamate receptors.
    Ribeiro FM; Pires RG; Ferguson SS
    Mol Neurobiol; 2011 Feb; 43(1):1-11. PubMed ID: 21153060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabotropic glutamate receptor 5 knockout promotes motor and biochemical alterations in a mouse model of Huntington's disease.
    Ribeiro FM; Devries RA; Hamilton A; Guimaraes IM; Cregan SP; Pires RG; Ferguson SS
    Hum Mol Genet; 2014 Apr; 23(8):2030-42. PubMed ID: 24282028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mGluR5 positive allosteric modulator VU0409551 improves synaptic plasticity and memory of a mouse model of Huntington's disease.
    Doria JG; de Souza JM; Silva FR; Olmo IG; Carvalho TG; Alves-Silva J; Ferreira-Vieira TH; Santos JT; Xavier CQS; Silva NC; Maciel EMA; Conn PJ; Ribeiro FM
    J Neurochem; 2018 Oct; 147(2):222-239. PubMed ID: 30028018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. mGluR5 antagonism increases autophagy and prevents disease progression in the
    Abd-Elrahman KS; Hamilton A; Hutchinson SR; Liu F; Russell RC; Ferguson SSG
    Sci Signal; 2017 Dec; 10(510):. PubMed ID: 29259100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting mutant huntingtin for the development of disease-modifying therapy.
    Appl T; Kaltenbach L; Lo DC; Terstappen GC
    Drug Discov Today; 2012 Nov; 17(21-22):1217-23. PubMed ID: 22772050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of mTOR and CREB pathways following mGluR5 blockade contribute to improved Huntington's pathology in zQ175 mice.
    Abd-Elrahman KS; Ferguson SSG
    Mol Brain; 2019 Apr; 12(1):35. PubMed ID: 30961637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of mutant huntingtin on mGluR5-mediated dual signaling pathways: implications for therapeutic interventions.
    Huang SS; He J; Zhao DM; Xu XY; Tan HP; Li H
    Cell Mol Neurobiol; 2010 Oct; 30(7):1107-15. PubMed ID: 20644995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabotropic glutamate receptor-mediated cell signaling pathways are altered in a mouse model of Huntington's disease.
    Ribeiro FM; Paquet M; Ferreira LT; Cregan T; Swan P; Cregan SP; Ferguson SS
    J Neurosci; 2010 Jan; 30(1):316-24. PubMed ID: 20053912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic Strategies for Huntington's Disease.
    Mrzljak L; Munoz-Sanjuan I
    Curr Top Behav Neurosci; 2015; 22():161-201. PubMed ID: 24277342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decrease of mGluR5 receptor density goes parallel with changes in enkephalin and substance P immunoreactivity in Huntington's disease: a preliminary investigation in the postmortem human brain.
    Gulyás B; Sovago J; Gomez-Mancilla B; Jia Z; Szigeti C; Gulya K; Schumacher M; Maguire RP; Gasparini F; Halldin C
    Brain Struct Funct; 2015 Sep; 220(5):3043-51. PubMed ID: 24969128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. mGluR5 regulates REST/NRSF signaling through N-cadherin/β-catenin complex in Huntington's disease.
    de Souza JM; Abd-Elrahman KS; Ribeiro FM; Ferguson SSG
    Mol Brain; 2020 Aug; 13(1):118. PubMed ID: 32859226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The metabotropic glutamate receptor 5 antagonist MPEP and the mGluR2 agonist LY379268 modify disease progression in a transgenic mouse model of Huntington's disease.
    Schiefer J; Sprünken A; Puls C; Lüesse HG; Milkereit A; Milkereit E; Johann V; Kosinski CM
    Brain Res; 2004 Sep; 1019(1-2):246-54. PubMed ID: 15306259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inositol 1,4,5-tripshosphate receptor, calcium signalling and Huntington's disease.
    Bezprozvanny I
    Subcell Biochem; 2007; 45():323-35. PubMed ID: 18193642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopaminergic signaling and striatal neurodegeneration in Huntington's disease.
    Tang TS; Chen X; Liu J; Bezprozvanny I
    J Neurosci; 2007 Jul; 27(30):7899-910. PubMed ID: 17652581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unraveling a role for dopamine in Huntington's disease: the dual role of reactive oxygen species and D2 receptor stimulation.
    Charvin D; Vanhoutte P; Pagès C; Borrelli E; Caboche J
    Proc Natl Acad Sci U S A; 2005 Aug; 102(34):12218-23. PubMed ID: 16103364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-type Ca
    Silva FR; Miranda AS; Santos RPM; Olmo IG; Zamponi GW; Dobransky T; Cruz JS; Vieira LB; Ribeiro FM
    Neurobiol Aging; 2017 Jul; 55():1-10. PubMed ID: 28391067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Foundation-directed therapeutic development in Huntington's disease.
    Dominguez C; Munoz-Sanjuan I
    J Med Chem; 2014 Jul; 57(13):5479-88. PubMed ID: 24432836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.